A revolution in allergy testing

Since adopting the S.P.A.T. device in 2023, Prof. Lefèbvre has witnessed a transformation in the way allergy tests are conducted in the ENT department at CHU Liège.
‍
Prof. Lefèbvre shares his insights on the device’s ability to standardise testing results, enhance efficiency, and improve both diagnostic precision and patient experience, making it an invaluable tool in modern allergy care.

“As a healthcare professional, I have had the opportunity to use the S.P.A.T. device for allergy testing, and I am truly impressed by the results.

This innovative device provides standardisation that not only improves the efficiency and accuracy of tests but also ensures diagnostic consistency. It is reassuring to know that variations in results due to the person performing the test are now eliminated.

The dual validation by artificial intelligence and physicians makes S.P.A.T. an essential reference in the field.
The economic benefits are also noteworthy: we can perform more tests per vial, allowing us to test a greater number of patients each day while reducing waiting times.

Moreover, the device reduces the workload of nursing staff, enabling them to dedicate more time on other critical tasks. For patients, the experience is more comfortable, as the tests are less painful, significantly enhancing overall satisfaction.

In summary, the S.P.A.T. device is not just a tool; it represents a true breakthrough that transforms how we approach allergy testing.

I am confident it will quickly become the new standard in our practice.”